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Potassium channels are essential for a variety of cellular processes ranging from membrane excitability to cellular proliferation. The KCNE
genes (KCNE1 –5) encode a family of single-transmembrane-domain proteins that modulate the properties of several potassium channels,
suggesting a physiologic role for these accessory subunits in many human tissues. To investigate the expression and transcriptional control of
KCNE genes we mapped transcription start sites, delineated 5V genomic structure, and characterized functional promoter elements for each gene.
We identified alternatively spliced transcripts for both KCNE1 and KCNE3, including a cardiac-specific KCNE1 transcript. Analysis of relative
expression levels of KCNE1 –5 in a panel of human tissues revealed distinct, but overlapping, expression patterns. The coexpression of multiple
functionally distinct KCNE genes in some tissues infers complex accessory subunit modification of potassium channels. Identification of the core
promoter elements necessary for transcriptional control of the KCNE genes facilitates future work investigating factors responsible for tissue-
specific expression as well as the discovery of promoter variants associated with disease.
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diverse classes of membrane proteins, with genes encodingmore
than 75 pore-forming subunits [1]. Voltage-gated potassium
(KV) channels constitute a large portion of this family and have
been implicated in a variety of physiological processes,
including membrane excitability, synaptic transmission, epithe-
lial transport, and cellular proliferation. The diversity of KV
channel activity is further expanded through associations
between pore-forming (a) and accessory (h) subunits. Several
distinct families of accessory h subunits can have profound
effects on biophysical properties, pharmacological responses,
tissue distribution, and trafficking of various KV channel a
subunits [2].
One important family of human potassium channel h
subunits is encoded by the five KCNE genes (KCNE1 –
KCNE5) [3,4]. In addition to amino acid sequence homology
within their single transmembrane domains, a common feature0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: al.george@vanderbilt.edu (A.L. George).of KCNE subunits is the ability to modulate KCNQ1 and other
voltage-gated channels in vitro. The most well studied example
is the interaction of KCNE1 with KCNQ1 to form the slow
component of the delayed rectifier current (IKs) essential for
normal cardiac repolarization [5,6]. KCNE2 and KCNE3 alter
activation and confer constitutive activity when coexpressed
with KCNQ1, with KCNE2 decreasing [7] and KCNE3
increasing [8] current magnitude. By contrast, KCNE4 and
KCNE5 inhibit heterologously expressed KCNQ1 channel
activity [9–11]. The physiological importance of KCNE genes
is illustrated by mutations in KCNE1-3 that have been
associated with inherited human diseases [12–17].
In this study, we defined the transcription start sites and 5V
flanking genomic sequences of each KCNE gene. These data
enabled discovery of alternatively spliced transcripts for
KCNE1 and KCNE3 and functional characterization of core
promoter regions for all genes except KCNE2. We further
examined relative mRNA levels of the five KCNE genes by
quantitative RT-PCR in multiple human tissues and identified
distinct but overlapping expression patterns. This study
provides evidence that KCNE genes are widely coexpressed,
suggesting that complex accessory subunit modulation of6) 119 – 128
www.el
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delineate critical genomic elements necessary for transcription-
al control of KCNE genes and thus enable future work to
determine factors responsible for tissue-specific expression.
Results
Genomic organization of human KCNE genes
Definition of the 5V genomic structure for each KCNE gene
enabled identification of promoter regions and relative mRNA
expression analysis in various human tissues. Transcription start
sites were mapped for each KCNE gene by the ribo-oligonucle-
otide ligation method of rapid amplification of cDNA ends
(RLM-RACE) [21], followed by nucleotide sequencing of
subcloned products. We identified exons containing the 5V
untranslated region (5V-UTR) of each gene by alignment of
RLM-RACE sequences with publicly available human genome
sequence. We did not determine the genomic organization of the
3V untranslated regions.
Two alternative transcription start sites were identified for
KCNE1 in cDNA derived from human ventricle, suggesting the
presence of multiple promoter regions. The transcripts origi-
nating from these two sites were designated KCNE1a (short 5V-
UTR, GenBank Accession No. AY789479) and KCNE1b (long
5V-UTR, GenBank Accession No. AY789480). Each transcript
contained identical coding regions, differing only by alternative
splicing of exons containing portions of the 5V-UTR (Fig. 1).
We identified one entry in GenBank corresponding to KCNE1a
(Accession No. BC036452), which extended an additional 49
nucleotides in the 5V direction, but no KCNE1b sequences were
identified in GenBank or databases of expressed sequence tagsFig. 1. Genomic organization of human KCNE genes. For each KCNE gene, black b
sequences correspond to experimentally determined exon boundaries (intronic seq
indicated by separate scale bars.(ESTs). KCNE3 also exhibited two alternative transcription
start sites resulting in two transcripts (KCNE3a for long 5V-
UTR; KCNE3b for short 5V-UTR, GenBank Accession Nos.
DQ192291, DQ192292). These transcripts differed only by the
presence of an additional exon in the 5V-UTR for KCNE3a
compared to KCNE3b. One human EST sequence (CR936625)
corresponded to KCNE3a exactly, whereas we found no
KCNE3b matches in the nucleotide databases. Single sites of
transcription initiation were identified in human ventricular
mRNA for KCNE2, KCNE4, and KCNE5 (Fig. 1, GenBank
Accession Nos. DQ192290, DQ192293, DQ192294), and the
corresponding 5V-UTRs extended 4–49 nucleotides 5V of
existing cDNA or EST sequences except one EST
corresponding to KCNE5, which originated from an RLM-
RACE library (AK223306). All KCNE genes except KCNE5
have exons containing 5V-UTR sequence separated from the
coding exon by variable-length introns (size range 0.5–5.1 kb).
Consensus splice site sequences including a 5V GT dinucleotide
and 3V AG dinucleotide were identified in each intron.
Relative KCNE gene expression in human tissues
To examine relative expression of KCNE genes in a variety
of human tissues, we employed real-time, quantitative RT-
PCR using 5V-nuclease chemistry and fluorogenic oligonucle-
otide (TaqMan) probes. To achieve a high level of specificity
and to avoid detection of genomic DNA, we designed probes
for each KCNE transcript to span exon–exon junctions,
except for KCNE5, which is intronless. We also assayed for
expression of KCNQ1, a KV channel a subunit reported to
interact with each member of the KCNE family in vitro.
Expression levels for each gene were determined by compar-oxes denote the 5V UTR, while white boxes indicate coding regions. Nucleotide
uences are in lower case). Intron and exon lengths are scaled differently as
A.L. Lundquist et al. / Genomics 87 (2006) 119–128 121ison to a standard curve that was assayed in parallel and the
results were normalized to glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) expression.
Fig. 2 illustrates the relative levels of all KCNE genes and
KCNQ1 across 15 different human tissues. As shown
previously [11], KCNE1 (KCNE1a + KCNE1b) exhibits the
most prominent expression in the heart, but levels of KCNE4,
KCNE3, and KCNE5 are also substantial in this tissue (Fig.
2A). Notably, we observed expression of the KCNE1b
transcript only in the heart. This suggests that the KCNE1b
transcript is cardiac specific, while KCNE1a is expressed in
several other tissues, including kidney, testes, and uterus (Figs.
2A and 2B). By contrast, we detected very low levels of
cardiac KCNE2 expression. KCNE2 expression was low across
the majority of tissues compared to the other members of the
KCNE family except in colon and small intestine (Fig. 2B).
KCNE3 is the most highly expressed KCNE gene across the
various tissues. High relative levels of KCNE3 and KCNQ1
were detected in kidney, prostate, and leukocytes, with minimal
expression of other KCNE family members in these tissues.Fig. 2. Relative expression of KCNQ1 and KCNE genes in human tissues. Several
grouped by low (A) and high (B) overall expression for display purposes (note diff
curves and results were normalized by GAPDH expression. Data are presented as me
cDNA samples isolated from healthy individuals.However, in other tissues such as the liver, ovary, and placenta,
we observed high relative levels of KCNE3 transcripts in the
absence of KCNQ1 expression. High levels of KCNE4 and
KCNE5 expression were detected in a variety of tissues.
Relative to the other KCNE genes, the greatest expression of
KCNE4 occurred in skeletal muscle, testes, spleen, and ovarian
tissue. High levels of KCNE5 expression were observed in the
brain, thymus, testes, spleen, ovaries, and placenta.
Identification of KCNE promoters
Mapping transcription start sites (TSS) for each KCNE gene
permitted identification and characterization of their putative
promoter regions. To delineate further genomic regions poten-
tially important for transcriptional control, we performedVISTA
[19] analysis across human and mouse sequences to identify
conserved noncoding elements. We cloned genomic DNA
surrounding each identified TSS into the pGL3basic plasmid,
which encodes firefly luciferase and lacks a resident promoter.
For each KCNE promoter construct, we determined luciferasehuman tissues were examined by real-time quantitative RT-PCR. Tissues were
erences in the y-axis scale). All data were quantified by gene specific standard
an T SEM for at least 6 replicates from 2 different pooled (2 or more individuals)
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monkey kidney cells (CosM6). When promoter activity was
observed, we tested nested deletions of the full-length cloned
promoter constructs. Data were normalized to the activity of a
second reporter (Renilla luciferase) to control for variation in
transfection.
KCNE1 promoter
Two distinct regions were identified corresponding to
putative promoters for KCNE1a and KCNE1b. Expression
of the putative KCNE1a promoter region (1278 to +257
relative to the TSS) resulted in high levels of normalized
luciferase activity in both CosM6 cells (40-fold) and HL-1
cells (16-fold) compared to nonrecombinant vector, suggest-
ing the identification of a functional promoter region (Figs.
3A and 3B). An unpaired 5V splice site belonging to the first
intron included in this construct elicits mRNA splicing to a
cryptic acceptor site 46 bp upstream of the luciferase start
codon. However, this splicing event preserves the complete
open reading frame of the reporter gene based on sequencing
of RT-PCR-generated amplicons from transfected cells (data
not shown). Truncation of the genomic region by removal of
1034 bp from the 5V end did not significantly affect reporter
activity, indicating that the core promoter was contained
within a 501-bp region (244 to +257) surrounding the TSS.
This hypothesis was confirmed by observing only background
luciferase activity when this region was removed (Fig. 3A). AFig. 3. KCNE1 sequence conservation and promoter analysis. Human and mouse gen
Peaks represent regions of conservation greater than 50%. The locations of untransla
The full length cloned promoter regions for both KCNE1a and KCNE1b are repre
relative to the transcription start site) for both KCNE1a and KCNE1b were subclone
(B). Nonrecombinant vector (promoterless pGL3basic vector) expression was norma
assayed in triplicate.consensus TATA box was not evident in the GC-rich region
upstream of the transcription start site, although two
conserved transcription factor binding sites (FXR, WHN)
were identified (Table 1).
Expression of the region surrounding the KCNE1b transcrip-
tion start site (1690 to +70) resulted in reporter activity
ninefold greater than the nonrecombinant vector in both CosM6
and HL-1 cells (Fig. 3B). Truncation of the 5V region led to
progressively less activity in the HL-1 cells, while significantly
increased activity was observed in CosM6 cells with the removal
of the region from1690 to921. In both cell types, removal of
a 450-bp region surrounding the KCNE1b TSS significantly
diminished reporter activity and is likely to contain the core
promoter region for this alternatively spliced transcript. There
was no identifiable TATA box, although several conserved
transcription factor binding sites were predicted, including
MYOD, GATA6, SRF, and SF1 (Table 1).
KCNE2 promoter
In a similar fashion, we cloned the genomic region (1546
to +30) surrounding the transcription start site identified for
KCNE2. However, expression of this construct, as well as
various deletion constructs, did not result in luciferase activity
significantly greater than background levels in either HL-1 or
CosM6 cells (data not shown). KCNE2 is not highly expressed
in heart or kidney, the two tissue types represented by the cell
lines used in our experiments, and the putative promoter mayomic sequence surrounding the KCNE1 locus was compared using VISTA (A).
ted exons (blue) and the coding exon (purple) are depicted above the alignment.
sented by black boxes. Full length and truncated promoter regions (described
d into pGL3basic (Promega) and assayed for activity in CosM6 and HL-1 cells
lized to a value of one. Data were compiled from three independent transfections
Table 1
Predicted transcription factor binding sites in KCNE genes
Gene Transcription
Factor
Position\
Strand
(bp relative
to TSS)
Conserved Binding Sitea
KCNE1a WHN 751\ TAGCGTTGCTC
FXR_IR1 888\+ GGTTCCTGACCTA
KCNE1b GATA6 153\+ CCTATCAGCACTGATAACAG
SF1 918\+ GTCCTTGG
MYOD 931\+ CCAACTGTCT
SRF 977\+ CTATGTCCAAATTTTGGA
KCNE3a SP1 61\ GCCCCGCCCGGC
SP1 113\ CCTCCGCCCAGCT
ETS 174\ CGCCTGCTTCCTGGA
KCNE3b ETS 120\ TCCCCTTCCTGC
GABP 120\ CCCCTTCCTGCA
NRF2 120\ CCTTCCTGCA
AP4 132\ CTGCAGCAGCTGGGTCAG
NFAT 976\ TTTTTCCTCTTC
KCNE4 MYOD 50\+ CAGAGCACGTGACGATGC
E4F1 50\+ TGACGATGCA
USF 50\+ GAGCACGTGACGAT
MYOD 780\+ AAAACCTGCCCA
KCNE5 STAT +84\+ GGAAGCGA
SP1 54\+ CTCCTCCCCTT
Muscle INI B 64\+ CCCTTCCCCACCACGCCCCCT
SP1 71\+ ACCACGCCCCCTC
GC 71\+ CACCACGCCCCCTC
OLF1 226\+ GCGAGGCCCCAGGCAGCAGACG
E2F 261\+ TTGGCCCA
AP2 276\+ ACCCTGGGCTGCGGAA
ROAZ 276\+ GACCCTGGGCTGCG
YY1 790\+ GTAAGCCATCTTCCCAGAAG
STAT 796\+ CCATCTTCCCAGAAGTGAAAC
a Sequence of binding site conserved between mouse and human predicted by
rVISTA with a matrix similarity of 85%.
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did not identify the true promoter region for KCNE2.
KCNE3 promoter
Two alternative transcription start sites were identified for
KCNE3 and a significant level of sequence conservation
between human and mouse was identified upstream of both
sites (Fig. 4A). Expression of a reporter construct encompass-
ing the KCNE3a site (1677 to +59) resulted in 40- and 20-
fold greater reporter activity in CosM6 and HL-1 cells,
respectively, compared to the nonrecombinant vector. Removal
of nucleotides 736 to 346 resulted in a 2.5-fold increase in
reporter activity in both CosM6 and HL-1 lines, suggesting that
this region may contain a suppressor element active in kidney
and heart cells (Fig. 4B). Deletion of 405 bp (346 to +59)
surrounding the KCNE3a transcription start site reduced
reporter activity to background levels, implicating this segment
as the location of the core promoter. The region upstream of the
TSS was GC rich, lacked a TATA box, and exhibited predicted
transcription factor binding sites (two SP1 and one ETS) that
were conserved between mouse and human (Table 1).
Expression of the region surrounding the KCNE3b start site
(1182 to +173) resulted in 10- and 6-fold increases in reporter
activity in CosM6 and HL-1 cells, respectively, although thisactivity was significantly less than that of KCNE3a. Removal of
the region from 1182 to 655 resulted in increased reporter
activity in both cell types, consistent with elimination of
suppressor element (Fig. 4B). This putative suppressor coincides
with a noncoding region of substantial conservation ¨750 bp
upstream of the TSS for KCNE3b (Fig. 4A). Further removal of
sequence from 655 to 283 reduced reporter levels to those
observed in the original (1182 to +173) construct. Elimination
of 283 bp surrounding the KCNE3b TSS resulted in basal levels
of reporter activity, indicating that the core promoter activity for
KCNE3b is contained within this region (Fig. 4B). Multiple
conserved transcription factor sites (NFAT, AP4, ETS) were
predicted upstream of the TSS, but no TATA box was present
(Table 1).
KCNE4 promoter
Alignment of human andmouse genomic sequence surround-
ing the KCNE4 locus revealed regions of significant conserva-
tion immediately 5V of the untranslated exon and two conserved
regions near the 3V-UTR (Fig. 5A). We tested the putative
promoter region surrounding the TSS (1249 to +56) contain-
ing highly conserved 5V sequences for transcriptional activity in
CosM6 and HL-1 cells. This putative KCNE4 promoter region
produced 40- and 27-fold increases in reporter activity in CosM6
andHL-1 cells, respectively. Stepwise removal of sequence from
the 5V end of the promoter region resulted in decreases in
luciferase activity in both cell types, implicating the importance
of the entire cloned region for reporter gene expression. A
deletion construct with 435 nucleotides removed from the region
surrounding the TSS retained a limited ability to drive
expression (Fig. 5B). Consensus CAAT and TATA boxes were
identified 84 and 31 bases upstream of the TSS, respectively, and
two conserved MYOD sites were predicted within the promoter
region (Table 1).
KCNE5 promoter
Comparison of human and mouse sequence surrounding the
KCNE5 locus revealed an extensive region of highly conserved
noncoding sequence immediately upstream of the 5V-UTR (Fig.
6A). Expression of the complete putative promoter region
(1381 to +105) resulted in substantially increased reporter
activity in CosM6 (60-fold) and HL-1 cells (30-fold) compared
to the promoterless vector. Truncation of 494 bp of the promoter
region from the 5V end reduced activity in HL-1 cells, but not in
CosM6 cells. However, removal of a 441-bp region surrounding
the TSS eliminated reporter activity in both cell types,
suggesting that the core promoter region is contained within
this sequence (Fig. 6B). It is notable that this region corresponds
well with the highly conserved noncoding region between
human and mouse (Fig. 6A) and multiple conserved transcrip-
tion factor binding sites were predicted in this region (Table 1).
Discussion
Potassium channels are involved in a wide range of
important physiological processes including maintenance of
the resting membrane potential, action potential duration,
Fig. 4. KCNE3 sequence conservation and promoter analysis. Human and mouse genomic sequence surrounding the KCNE3 locus was compared using VISTA (A).
Peaks represent regions of conservation greater than 50%, while regions of conservation of greater than 75% for 100+ bp are shaded orange. The locations of
untranslated exons (blue) and the coding exon (purple) are depicted above the alignment. The full length cloned promoter regions for both KCNE3a and KCNE3b are
represented by black boxes. Full length and truncated promoter regions (described relative to the transcription start site) for both KCNE3a and KCNE3b were
subcloned into pGL3basic (Promega) and assayed for activity in CosM6 and HL-1 cells (B). Nonrecombinant vector (promoterless pGL3basic vector) expression
was normalized to a value of one. Data were compiled from three independent transfections assayed in triplicate.
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expression of pore-forming a subunits often require coexpres-
sion of accessory h subunits to recapitulate biophysical
properties, pharmacological responses, and normal trafficking
associated with native potassium channels [2]. The KCNE
genes represent one class of accessory subunits that modulate a
variety of a subunits and are associated with multiple inherited
human diseases.
The promiscuity of KCNE subunits in heterologous systems
complicates the interpretation of their physiologic relevance. In
addition to KCNQ1, studies indicate that KCNE1 may interact
with HERG [22] and Kv4.3 [23]. KCNE2 has been implicated
as an accessory subunit for HERG [15] channels and may
modulate hyperpolarization-activated cation channel-4 [24],
Kv4.2 [25], and Kv4.3 [23]. KCNE3 can also modulate HERG
[8] and Kv3.4 [26]. KCNE4 has recently been shown to inhibit
heterologously expressed Kv1.1 and Kv1.3 channels but to
have no effects on a variety of other voltage-gated potassium
channels (Kv1.2, Kv1.4, Kv1.5, and Kv4.3) [27]. To date,
KCNE5 has been demonstrated only to interact biophysically
with KCNQ1 [10]. The list of potassium channels that may
interact with the various KCNE subunits continues to grow and
fuel further speculations about their multiple physiological
roles. Regulation of a single a subunit by multiple KCNE
family members creates another level of channel complexity.The potential for complex modulation of potassium channels by
KCNE subunits motivated our survey of relative KCNE
expression across a number of human tissues and an effort to
characterize the transcriptional regulation of these genes.
Expression profiling of KCNE genes
Examination of relative KCNE gene expression across
human tissues revealed patterns of expression that are not
evident by examination of single KCNE family members.
Some tissues, such as the heart and the testes, express similar
relative levels of multiple KCNEs, emphasizing the potential
for convergent regulation of a subunits by multiple KCNE
subunits. Other tissues such as brain, uterus, liver, and
leukocytes express one predominant KCNE. Examination of
these expression patterns in human tissues is informative and
important as previous studies have demonstrated a species-
specific pattern of expression of ion channel subunits [28].
The human KCNE1a transcript has been described [29], but
to our knowledge this is the first evidence of an alternative
KCNE1 transcript expressed in human heart. KCNE1b appears
to be cardiac specific, while KCNE1a was expressed at high
levels in heart, kidney, testes, and uterus. Expression of
KCNE1a was always accompanied by prominent expression
of KCNQ1. In the uterus, KCNE1a and KCNQ1 are expressed
Fig. 5. KCNE4 sequence conservation and promoter analysis. Human and mouse genomic sequence surrounding the KCNE4 locus was compared using VISTA (A).
Peaks represent regions of conservation greater than 50%, while regions of conservation of greater than 75% for 100+ bp are shaded orange. The locations of
untranslated exons (blue) and the coding exon (purple) are depicted above the alignment. The full length cloned promoter region for KCNE4 is marked by the black
box. Full length and truncated promoter regions (described relative to the transcription start site) for KCNE4 were subcloned into pGL3basic (Promega) and assayed
for activity in CosM6 and HL-1 cells (B). Nonrecombinant vector (promoterless pGL3basic vector) expression was normalized to a value of one. Data were compiled
from three independent transfections assayed in triplicate.
A.L. Lundquist et al. / Genomics 87 (2006) 119–128 125in the relative absence of other KCNE genes, suggesting that an
IKs channel complex may be generated that has some role in
uterine physiology.
Significant expression of KCNE2 was limited to the colon
and small intestine, while KCNE3 was the most highly
expressed family member across all tissues studied. In the
kidney, colon, prostate, and leukocytes, high levels of KCNE3
expression coincided with expression of KCNQ1, indicating
the existence of the molecular components needed to generate a
constitutively active channel as observed by coexpression of
these two proteins in vitro [8]. However, in the liver and the
ovaries significant expression of KCNE3 occurred in the
absence of KCNQ1, implying interaction with a different a
subunit. Accordingly, in skeletal muscle KCNE3 interacts with
Kv3.4, and a mutation in KCNE3 has been implicated in
familial periodic paralysis [17].
KCNE4 was expressed in a variety of human tissues.
Previous studies demonstrated that KCNE4 can inhibit several
potassium channel a subunits including KCNQ1, Kv1.1, and
Kv1.3 [9,11,27], which are coexpressed in many of the same
tissues as KCNE4. High levels of KCNE4 expression were
consistently accompanied by at least one additional member of
the KCNE family, often KCNE3. KCNE3 and KCNE4
typically have stimulatory and inhibitory effects on a subunits,
respectively, generating the potential for variable modulation ofpore-forming subunits through expression of multiple acces-
sory subunits [11].
High levels of KCNE5 expression were observed in the
brain, thymus, placenta, and ovaries, mostly in the absence of
KCNQ1. These results suggest that KCNE5 interacts with
another a-subunit. Notably, KCNE5 is expressed at signifi-
cantly higher levels in the brain compared to other KCNE
family members. KCNE5 is located on the X chromosome and
recent evidence identified an unusually large number of genes
coding for brain function on this chromosome [30].
Transcriptional control of KCNE genes
Mapping the TSS for each KCNE gene revealed that all
family members other than KCNE5 contain a noncoding exon
in the 5V-UTR that is separated from the coding region by a
large intron. Such noncoding exons are quite common, with a
frequency of >35% in human genes [31]. The sequence
surrounding each TSS closely resembled the Inr consensus
sequence: Py-Py-A+1-N-T/A-Py-Py (where A+1 is the tran-
scription start site). The Inr element surrounds the TSS and is
sufficient to direct accurate initiation in both TATA-containing
and TATA-deficient promoters [32].
Alignment of human and mouse sequence in the vicinity of
the coding region of each KCNE revealed segments of
Fig. 6. KCNE5 sequence conservation and promoter analysis. Human and mouse genomic sequence surrounding the KCNE5 locus was compared using VISTA (A).
Peaks represent regions of conservation greater than 50%, while regions of conservation of greater than 75% for 100+ bp are shaded orange. The locations of
untranslated exons (blue) and the coding exon (purple) are depicted above the alignment. The full length cloned promoter region for KCNE5 is marked by the black
box. Full length and truncated promoter regions (described relative to the transcription start site) for KCNE5 were subcloned into pGL3basic (Promega) and assayed
for activity in CosM6 and HL-1 cells (B). Basic vector (promoterless pGL3basic vector) expression was normalized to a value of one. Data were compiled from three
independent transfections assayed in triplicate.
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around the experimentally defined transcription start sites. This
conservation suggests that important regulatory elements are
contained within the sequence. Prediction of regulatory motifs
in silico has been successful for several genes [33–35]. Using
this approach, we identified several predicted transcription
factor binding sites immediately 5V of the transcription start site
for each KCNE gene (Table 1), whereas conserved binding
sites were largely absent from intronic regions.
Several conserved muscle- and cardiac-specific transcription
factors were identified in the promoter region of the cardiac-
specific transcript KCNE1b. Serum response factor (SRF) may
play a role in the commitment of cardiac progenitors and is
abundant in embryonic and adult cardiac, skeletal muscle, and
smooth muscle cells [36,37]. Additional evidence indicates that
combinatorial interactions between SRF and GATA-6, also
conserved in the KCNE1b promoter region, may facilitate
expression of heart-restricted genes, implicating these factors in
the cardiac-specific expression of KCNE1b [38]. The KCNE4
promoter exhibited consensus CAAT and TATA boxes and two
conserved MYOD binding sites, consistent with the high
relative expression of KCNE4 in skeletal muscle compared to
the other KCNE genes. The KCNE5 core promoter region
exhibited conserved binding sites for SP1, GC, and AP2, aswell as two neuronal transcription factors (OLF1 and ROAZ),
which may influence the high relative expression of KCNE5 in
the brain.
Further studies will be necessary to determine the functional
significance of these predicted transcription factor binding
sites. In this study we took a conservative approach by
annotating only those sites that were conserved between mouse
and human and met a high stringency for matrix similarity. It is
possible that other important binding sites exist that did not
satisfy these stringent criteria.
The identification of the TSS also facilitated the testing of
putative promoter regions surrounding the TSS containing
conserved transcription factor binding sites for the ability to
drive reporter activity. Significant luciferase activity was
identified for all reporter constructs tested, except those for
KCNE2. These results suggest that cloned genomic regions for
KCNE1 and KCNE3 –5 contain core promoter elements. It is
likely that other regulatory elements such as enhancer and
suppressor regions exist outside the core promoter for each of
these genes. The absence of more distant regulatory regions
controlling tissue-specific expression may help explain why
reporter gene activity in transfected kidney-derived cells does
not exactly parallel mRNA levels observed in kidney.
Regardless, knowledge of the core promoter regions provides
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sion and for screening KCNE genes for genetic variants that
alter mRNA expression in disease susceptibility states.
In summary, we have characterized the 5V genomic
structure for each of the KCNE genes, identifying multiple
human transcripts for KCNE1 and KCNE3. We compared
relative expression patterns of all KCNE genes across a
variety of human tissues to characterize the complement of
accessory subunits in each tissue. Expression results were
consistent with many previous studies implicating KCNE
genes in both normal physiology and disease and suggested
additional human tissues in which KCNE genes may have
important functions. We identified functional core promoter
elements in genomic regions highly conserved between human
and mouse for each of the KCNE genes, except KCNE2.
These data provide highly valuable knowledge of core
elements related to tissue-specific regulation and identify
targets for studies of genetic variants in diseases associated
with the KCNE genes.
Materials and methods
Transcription start site mapping
Total RNA was extracted from normal human ventricle using Trizol
reagent (Invitrogen Corp., Carlsbad, CA, USA), quantified by UV spectro-
photometry, and examined for integrity using denaturing agarose gel
electrophoresis. Messenger RNA (poly(A)+) was isolated from 10 Ag of total
RNA using Oligotex resin (Qiagen, Inc., Valencia, CA, USA). Ventricular
poly(A)+ RNA (250 ng) was processed according to the RLM-RACE protocol
(Ambion, Inc., Austin, TX, USA) to create random hexamer-primed cDNA
anchored to a known 5V oligonucleotide sequence. Transcription start sites
were identified by PCR amplification using a gene-specific reverse primer
(located approximately 200 bp 3V of the ATG start codon) and a forward
anchor primer. Specific products were identified by Southern blot hybridiza-
tion using biotinylated sense oligonucleotide probes (15 bp, beginning at the
ATG start codon) and a chemiluminescence detection system (North2South;
Pierce Biotechnology, Inc., Rockford, IL, USA). Southern blot positive
products were subcloned into pCR2.1-TOPO (Invitrogen) and sequenced.
Multiple independent clones (6–10) were sequenced for each identified
transcript.
Real-time quantitative RT-PCR
Complementary DNAs synthesized using RNA isolated from normal
human tissues were obtained from a commercial source (MTC Panels I and
II; BD Biosciences–Clontech, Palo Alto, CA, USA). Each cDNA sample in
these panels was synthesized using pooled RNA isolated from at least two
normal adult Caucasians (males and females) and the concentration was
standardized according to expression data of four housekeeping genes (a-
tubulin, h-actin, GAPDH, phospholipase A2). Human uterine tissue was
obtained from the National Disease Research Interchange (NDRI, Philadelphia,
PA, USA).
Fluorescently labeled TaqMan (Applied Biosystems, Foster City, CA, USA)
probes for KCNQ1 and KCNE1 –4 were designed to span an exon–exon
boundary within the coding region and 5V-untranslated regions, respectively,
while a probe for KCNE5 targeted a continuous region of coding sequence in
the single exon. We developed assays specific to KCNE1a and KCNE1b, but
were unable to assay for expression of KCNE3a and KCNE3b separately
because there were no distinct exon–exon boundaries. Primer sets amplifying
99- to 104-bp segments surrounding each probe were designed using
PrimerExpress (Applied Biosystems). Sequences for all amplification primers
and gene-specific probes were published previously [11]. No amplification was
observed after 45 cycles of PCR in control reactions containing water as thetemplate. For each tissue, results were compared to a gene-specific standard
curve and normalized to expression of GAPDH, in the same samples. Template
used for determining standard curves consisted of plasmid DNA containing the
expected target sequence quantitated by PicoGreen fluorescence (Molecular
Probes, Eugene, OR, USA).
Reporter-gene promoter assays
For each KCNE gene, a region surrounding the TSS was amplified by PCR
from human genomic DNA. Putative promoter regions were subcloned into the
promoterless luciferase vector, pGL3basic (Promega Corp., Madison, WI,
USA), upstream of the firefly luciferase coding region. Nested truncations of
each promoter construct were created by using native restriction endonuclease
sites. Monkey kidney cells (CosM6) and murine cardiac myocytes (HL-1) [18]
were seeded in 24-well plates and transfected with 1 Ag of each promoter
construct or the nonrecombinant pGL3basic vector. In the same cells, 0.1 Ag of
pRL-TK (Promega), containing the coding region of Renilla luciferase driven
by the thymidine kinase promoter, was cotransfected in each well to provide an
index of cell viability and transfection efficiency. Forty-eight hours after
transfection, cells were washed in phosphate-buffered saline (137 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4) and lysed. Cell
lysates were assayed sequentially on a LumiCount luminometer (Perkin–
Elmer, Meriden, CT, USA) for firefly luciferase activity followed by Renilla
luciferase activity according to the Dual-Luciferase protocol (Promega). Firefly
luciferase values were normalized to Renilla activity, and normalized values
were scaled to depict fold increase in activity over the nonrecombinant pGL3b
vector. Data were compiled from three independent transfections assayed in
triplicate.
Annotation of transcription factor binding sites
Human and murine genomic sequences surrounding the coding region of
each KCNE gene were compared using VISTA [19] to identify noncoding
regions with nucleotide conservation greater than 75% over a 100-bp window.
Conserved transcription factor binding sites in the vicinity of the transcription
start site were predicted by rVista [20] utilizing the vertebrate TRANSFAC
transcription factor library. Search parameters were optimized for identifica-
tion of functional sites with a matrix similarity of 85% or greater to the
consensus binding sequence of a given transcription factor.
Acknowledgments
This work was supported by research grants from the NIH
(HL68880 to A.L.G.) and NIH institutional training grants
(GM007347 and NS07491 to A.L.L. and L.B., respectively).
References
[1] P.A. Anderson, R.M. Greenberg, Phylogeny of ion channels: clues to
structure and function, Comp. Biochem. Physiol B Biochem. Mol. Biol.
129 (2001) 17–28.
[2] M. Pourrier, G. Schram, S. Nattel, Properties, expression and potential
roles of cardiac K+ channel accessory subunits: MinK, MiRPs, KChIP,
and KChAP, J. Membr. Biol. 194 (2003) 141–152.
[3] G.W. Abbott, S.A. Goldstein, A superfamily of small potassium
channel subunits: form and function of the MinK-related peptides
(MiRPs), Q. Rev. Biophys. 31 (1998) 357–398.
[4] G.W. Abbott, S.A. Goldstein, F. Sesti, Do all voltage-gated potassium
channels use MiRPs? Circ. Res. 88 (2001) 981–983.
[5] M.C. Sanguinetti, et al., Coassembly of KvLQT1 and minK (IsK) proteins
to form cardiac IKs potassium channel, Nature 384 (1996) 80–83.
[6] J. Barhanin, et al., KvLQT1 and IsK (minK) proteins associate to form the
IKs cardiac potassium current, Nature 384 (1996) 78–80.
[7] N. Tinel, S. Diochot, M. Borsotto, M. Lazdunski, J. Barhanin, KCNE2
confers background current characteristics to the cardiac KCNQ1
potassium channel, EMBO J. 19 (2000) 6326–6330.
A.L. Lundquist et al. / Genomics 87 (2006) 119–128128[8] B.C. Schroeder, et al., A constitutively open potassium channel formed by
KCNQ1 and KCNE3, Nature 403 (2000) 196–199.
[9] M. Grunnet, et al., KCNE4 is an inhibitory subunit to the KCNQ1
channel, J Physiol (London) 542 (2002) 119–130.
[10] K. Angelo, et al., KCNE5 induces time- and voltage-dependent
modulation of the KCNQ1 current, Biophys. J. 83 (2002) 1997–2006.
[11] A.L. Lundquist, et al., Expression of multiple KCNE genes in human heart
may enable variable modulation of IKs, J. Mol. Cell Cardiol. 38 (2005)
277–287.
[12] I. Splawski, M. Tristani-Firouzi, M.H. Lehmann, M.C. Sanguinetti, M.T.
Keating, Mutations in the hminK gene cause long QT syndrome and
suppress IKs function, Nature Genet. 17 (1997) 338–340.
[13] I. Splawski, et al., Spectrum of mutations in long-QT syndrome genes:
KVLQT1, HERG, SCN5A, KCNE1, and KCNE2, Circulation 102 (2000)
1178–1185.
[14] L. Bianchi, et al., Cellular dysfunction of LQT5-minK mutants:
abnormalities of IKs, IKr and trafficking in long QT syndrome, Hum.
Mol. Genet. 8 (1999) 1499–1507.
[15] G.W. Abbott, et al., MiRP1 forms IKr potassium channels with HERG and
is associated with cardiac arrhythmia, Cell 97 (1999) 175–187.
[16] D. Isbrandt, et al., Identification and functional characterization of a novel
KCNE2 (MiRP1) mutation that alters HERG channel kinetics, J. Mol.
Med. 80 (2002) 524–532.
[17] G.W. Abbott, et al., MiRP2 forms potassium channels in skeletal muscle
with Kv3.4 and is associated with periodic paralysis, Cell 104 (2001)
217–231.
[18] W.C. Claycomb, et al., HL-1 cells: a cardiac muscle cell line that contracts
and retains phenotypic characteristics of the adult cardiomyocyte, Proc.
Natl. Acad. Sci. USA 95 (1998) 2979–2984.
[19] K.A. Frazer, L. Pachter, A. Poliakov, E.M. Rubin, I. Dubchak, VISTA:
computational tools for comparative genomics, Nucleic Acids Res. 32
(2004) W273–W279.
[20] G.G. Loots, I. Ovcharenko, rVISTA 2.0: evolutionary analysis of
transcription factor binding sites, Nucleic Acids Res. 32 (2004)
W217–W221.
[21] K. Maruyama, S. Sugano, Oligo-capping: a simple method to replace the
cap structure of eukaryotic mRNAs with oligoribonucleotides, Gene 138
(1994) 171–174.
[22] T.V. Mcdonald, et al., A minK-HERG complex regulates the cardiac
potassium current IKr, Nature 388 (1997) 289–292.
[23] I. Deschenes, G.F. Tomaselli, Modulation of Kv4.3 current by accessory
subunits, FEBS Lett. 528 (2002) 183–188.[24] N. Decher, F. Bundis, R. Vajna, K. Steinmeyer, KCNE2 modulates
current amplitudes and activation kinetics of HCN4: influence of
KCNE family members on HCN4 currents, Pflugers Arch. 446 (2003)
633–640.
[25] R.E. Greenblatt, Y. Blatt, M. Montal, The structure of the voltage-sensitive
sodium channel, FEBS Lett. 193 (1985) 125–134.
[26] G.W. Abbott, et al., MiRP2 forms potassium channels in skeletal muscle
with Kv3.4 and is associated with periodic paralysis, Cell 104 (2001)
217–231.
[27] M. Grunnet, H.B. Rasmussen, A. Hay-Schmidt, M. Rosenstierne, D.A.
Klaerke, KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium
channels, Biophys. J. 85 (2003) 1525–1537.
[28] S. Zicha, et al., Molecular basis of species-specific expression of
repolarizing K+ currents in the heart, Am. J. Physiol. Heart Circ. Physiol.
285 (2003) H1641–H1649.
[29] I. Splawski, et al., Genomic structure of three long QT syndrome genes:
KVLQT1, HERG, and KCNE1, Genomics 51 (1998) 86–97.
[30] M.T. Ross, et al., The DNA sequence of the human X chromosome,
Nature 434 (2005) 325–337.
[31] M.Q. Zhang, Statistical features of human exons and their flanking
regions, Hum. Mol. Genet. 7 (1998) 919–932.
[32] A.K. Kutach, J.T. Kadonaga, The downstream promoter element DPE
appears to be as widely used as the TATA box in Drosophila core
promoters, Mol. Cell Biol. 20 (2000) 4754–4764.
[33] W.W. Wasserman, M. Palumbo, W. Thompson, J.W. Fickett, C.E.
Lawrence, Human-mouse genome comparisons to locate regulatory sites,
Nature Genet. 26 (2000) 225–228.
[34] X. Xie, et al., Systematic discovery of regulatory motifs in human
promoters and 3V UTRs by comparison of several mammals, Nature 434
(2005) 338–345.
[35] G.G. Loots, et al., Identification of a coordinate regulator of interleukins 4,
13, and 5 by cross-species sequence comparisons, Science 288 (2000)
136–140.
[36] N.S. Belaguli, L.A. Schildmeyer, R.J. Schwartz, Organization and
myogenic restricted expression of the murine serum response factor gene.
A role for autoregulation, J. Biol. Chem. 272 (1997) 18222–18231.
[37] J.D. Croissant, et al., Avian serum response factor expression restricted
primarily to muscle cell lineages is required for alpha-actin gene
transcription, Dev. Biol. 177 (1996) 250–264.
[38] N.S. Belaguli, et al., Cardiac tissue enriched factors serum response
factor and GATA-4 are mutual coregulators, Mol. Cell Biol. 20 (2000)
7550–7558.
